Biodexa Pharmaceuticals
BDRX | NASDAQ
$2.80
-$0.63 (-18.37%)
At close: Nov 2, 2026, 4:00 PM ET
$2.98
+$0.18 (+6.43%)
After-hours:
Nov 2, 2026, 5:04 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | n/a | -153.15 | -191.41 | -372.25 | -708.23 | -219.39 | -19.05 | -687.17 | -2.46K | -3.07K | -3.58K |
PEG Ratio | n/a | 1.71 | 3.29 | 5.85 | 10.82 | 2.39 | 0.20 | -19.51 | -93.63 | 56.96 | 119.81 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 32.9K | 4.05K | 9.23K | 27.08K | 52.87K | 66.11K |
PB Ratio | 34.29 | 668.31 | 278.40 | 519.98 | 1.33K | 2.68K | 404.44 | 2.04K | 2.33K | 2.92K | 10.15K |
P/FCF Ratio | -47.15 | -1.35K | -276.04 | -331.97 | -1.49K | -1.83K | -288.73 | -907.76 | -2.65K | -4.83K | -6.76K |
P/OCF Ratio | -47.20 | -1.35K | -295.95 | -352.93 | -1.5K | -1.84K | -290.02 | -915.75 | -2.71K | -5.09K | -7.16K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -3.55K | -1.3K | -1.52K | -756.20 | -1.64K | -775.06 |
Debt / Equity Ratio | n/a | 0.01 | 0.04 | 0.09 | 0.04 | 0.10 | 0.10 | 0.20 | 0.10 | 0.06 | 0.22 |
Quick Ratio | 2.41 | 2.03 | 3.63 | 1.75 | 2.16 | 1.26 | 3.18 | 2.47 | 5.28 | 6.39 | 1.83 |
Current Ratio | 2.41 | 2.03 | 3.63 | 1.75 | 2.16 | 1.26 | 3.18 | 2.47 | 5.28 | 6.39 | 1.83 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.01 | 0.04 | 0.04 | 0.05 | 0.01 | 0.05 |
Interest Coverage | -930.91 | -226.39 | -40.16 | -134.49 | -86.18 | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -19.67% | -22.50% | -33.28% | -29.09% | -37.91% | -75.05% | -67.33% | -145.32% | -40.86% | -22.06% | -84.06% |
Return on Assets | -14.86% | -14.12% | -25.67% | -16.38% | -23.68% | -33.30% | -44.81% | -83.17% | -31.62% | -17.86% | -38.11% |
Return on Invested Capital | -48.03% | -38.88% | -31.26% | -45.69% | -37.56% | -70.93% | -67.21% | -90.47% | -41.48% | -28.49% | -65.93% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | -2.61K% | -655.37% | -1.07K% | -415.60% | -1.39K% | -401.25% |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -4.23K% | -1.2K% | -1.99K% | -654.06% | -1.3K% | -786.53% |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -4.37K% | -1.29K% | -2.2K% | -726.07% | -1.53K% | -845.39% |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -4.54K% | -1.42K% | -1.64K% | -807.26% | -2.13K% | -806.48% |
FCF Margin | n/a | n/a | n/a | n/a | n/a | -3.57K% | -1.3K% | -1.53K% | -763.25% | -1.71K% | -822.19% |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -2.67K% | -1.38K% | -1.57K% | -768.86% | -2K% | -761.63% |
Add to Watchlist
Select watchlists to add or remove BDRX